Magzter GOLD ile Sınırsız Olun

Magzter GOLD ile Sınırsız Olun

Sadece 9.000'den fazla dergi, gazete ve Premium hikayeye sınırsız erişim elde edin

$149.99
 
$74.99/Yıl

Denemek ALTIN - Özgür

Uneven field

THE WEEK India

|

July 27, 2025

Why retail traders keep losing big in derivatives market

- NACHIKET KELKAR

Uneven field

India's derivatives market has exploded in recent years, drawing in millions of eager retail traders chasing quick profits through futures and options trading.

These contracts, where two parties agree to trade a stock at a set price on a future date, have fuelled a frenzy of speculation. In April 2025, India accounted for nearly 60 per cent of the 7.3 billion equity derivatives traded globally. But a recent study by the Securities and Exchange Board of India (SEBI) reveals a grim truth—91 per cent of individual traders lost money in the equity derivatives segment in the financial year ending March 2025.

The derivatives market has grown at a breakneck pace, with the average daily turnover soaring from ₹92,724 crore in 2019-20 to ₹2.64 lakh crore in 2024-25—a 23 per cent compounded annual growth rate. Many factors contributed to this surge. The Covid-19 lockdown left many with extra time and savings, prompting them to try their hand at trading. User-friendly apps, low-cost trading plans from discount brokers, and mobile trading tools made it easier than ever to jump in. Social media and financial influencers further hyped the market, turning trading into a cultural phenomenon.

But the excitement masks a harsh reality. SEBI's data, which tracks trading from 2021-22, shows that nine out of 10 individual traders lose money. Total losses have climbed from ₹40,824 crore in 2022 to ₹1.06 lakh crore in 2025.

THE WEEK India'den DAHA FAZLA HİKAYE

THE WEEK India

THE WEEK India

Fire, smoke and soaring worries

The PSLV C-62 fiasco is a stress test of ISRO's technical systems, organisational processes and market credibility

time to read

7 mins

January 25, 2026

THE WEEK India

THE WEEK India

The dinosaur and the dictator

Dictators have a few things in common with T. rex, the king of dinosaurs. Both dominate their sphere of influence through brute force.

time to read

2 mins

January 25, 2026

THE WEEK India

We are developing master plans for tourism destinations

Across the world, the tourism development is more about providing seamless connection and basic infra like transportation, lodging and boarding.

time to read

2 mins

January 25, 2026

THE WEEK India

THE WEEK India

A TIGHTROPE WALK

As small-caps are yet to find valuation comfort, 2026 would be a challenging year for them

time to read

4 mins

January 25, 2026

THE WEEK India

THE WEEK India

ON THIN ICE

With the intensification of great-power rivalries in the region, Greenland's strategic and resource potential has become salient

time to read

5 mins

January 25, 2026

THE WEEK India

THE WEEK India

Elgin, Ephesus and Erdogan

Lord Elgin was wrong. Not the eighth earl whom we know as a viceroy of India, but his more famous father, the seventh who had carted away the Parthenon Marbles from Athens during 1802-1812. Elgin feared the Ottoman Turks, who had occupied Greece, might vandalise them.

time to read

2 mins

January 25, 2026

THE WEEK India

THE WEEK India

Art at the heart

The sixth edition of the Kochi-Muziris Biennale reclaims its legacy

time to read

6 mins

January 25, 2026

THE WEEK India

THE WEEK India

BENIGN PROSTATIC HYPERPLASIA (BPH): Understanding Symptoms, Diagnosis & Modern Treatment Options

Benign Prostatic Hyperplasia (BPH) is a very common medical condition affecting aging men, particularly those above 50 years.

time to read

2 mins

January 25, 2026

THE WEEK India

THE WEEK India

ERA OF THE NEW NORMAL

The confrontations with China and Pakistan have added another dimension to the ever-evolving nature of the Indian military

time to read

5 mins

January 25, 2026

THE WEEK India

THE WEEK India

Affordable CAR-T Therapy Brings New Hope for Blood Cancer Patients in India

For thousands of Indians battling blood cancers, a once-unimaginable dream is fast becoming reality. Cutting-edge CART cell therapy a breakthrough treatment that uses a patient's own immune system to fight cancer is now available in India at a fraction of global costs, offering renewed hope to patients with advanced disease.

time to read

1 mins

January 25, 2026

Listen

Translate

Share

-
+

Change font size